InsiderClue

Insider trading

Period: 120 months Stock: EOLS Minimum amount: $100K × + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

Create an account Sign in
When Periodin use
Who Role
The trade Type of trade Minimum amountin use Plan Share of their own holding
Ownership What the chief executive holds
When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

1 month 12 months 120 months
88 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

Anyone CEO CFO Other officers Directors 10% owners
88 decisions over 120 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

Any88 Buys33 Sells55 Cluster buys
88 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

Any $100K or more $1M or more $10M or more $100M or more $500M or more
88 decisions over 120 months Remove this filter
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
Any Discretionary Scheduled (10b5-1) Not stated Not on a plan
88 decisions over 120 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
88 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

88 decisions over 120 months
Stock
Insider
Type ?
Value ↓
Of own stake ↓
Why it stands out
EOLS Evolus, Inc.
2 Sep 2026
MOATAZEDI DAVID See Remarks
Sold at will
$950.02K 105,108 at 9.04
17.4%
Not planned
EOLS Evolus, Inc.
17 Mar 2026
MOATAZEDI DAVID See Remarks
Sold on a plan
$570.56K 116,720 at 4.89
15.9%
Planned (10b5-1)
EOLS Evolus, Inc.
17 Mar 2026
Avelar Rui See Remarks
Sold on a plan
$146.63K 29,996 at 4.89
6.5%
Planned (10b5-1)
EOLS Evolus, Inc.
15 Aug 2025
Stewart Brady Director
Bought
$204.49K 30,000 at 6.82
51.2%
First buy on file
EOLS Evolus, Inc.
16 Jun 2025
MOATAZEDI DAVID See Remarks
Sold at will
$164.05K 16,582 at 9.89
4.3%
Not planned
EOLS Evolus, Inc.
13 Jun 2025
MOATAZEDI DAVID See Remarks
Sold at will
$1.12M 111,323 at 10.05
22.6%
Not planned
EOLS Evolus, Inc.
9 Jun 2025
White Albert G III Director
Bought
$189.00K 20,000 at 9.45
65.8%
First buy on file
EOLS Evolus, Inc.
12 May 2025
MOATAZEDI DAVID See Remarks
Sold on a plan
$155.76K 15,787 at 9.87
3.1%
Planned (10b5-1)
EOLS Evolus, Inc.
18 Mar 2025
MOATAZEDI DAVID See Remarks
Sold on a plan
$1.37M 103,376 at 13.26
16.7%
Planned (10b5-1)
EOLS Evolus, Inc.
18 Mar 2025
Avelar Rui See Remarks
Sold on a plan
$369.87K 27,904 at 13.26
7.1%
Planned (10b5-1)
EOLS Evolus, Inc.
18 Mar 2025
Beaver Sandra Chief Financial Officer
Sold on a plan
$119.24K 8,996 at 13.26
4.9%
Planned (10b5-1)
EOLS Evolus, Inc.
12 Mar 2025
Parschauer Karah Herdman Director
Sold at will
$167.47K 12,888 at 12.99
28.6%
Not planned
EOLS Evolus, Inc.
23 Dec 2024
MOATAZEDI DAVID See Remarks
Sold on a plan
$113.97K 10,502 at 10.85
2.0%
Planned (10b5-1)
EOLS Evolus, Inc.
6 Jun 2024
MOATAZEDI DAVID See Remarks
Sold at will
$2.21M 175,940 at 12.59
24.8%
Not planned
EOLS Evolus, Inc.
5 Jun 2024
MOATAZEDI DAVID See Remarks
Sold at will
$2.01M 155,278 at 12.92
22.5%
Not planned
EOLS Evolus, Inc.
4 Jun 2024
MOATAZEDI DAVID See Remarks
Sold at will
$1.78M 140,214 at 12.73
20.8%
Not planned
EOLS Evolus, Inc.
13 May 2024
Malik Vikram Director
Sold at will
$362.01K 28,000 at 12.93
9.9%
Not planned
EOLS Evolus, Inc.
10 May 2024
MOATAZEDI DAVID See Remarks
Sold at will
$204.13K 16,051 at 12.72
2.3%
Not planned
EOLS Evolus, Inc.
19 Mar 2024
MOATAZEDI DAVID See Remarks
Sold at will
$1.34M 96,566 at 13.92
12.2%
Not planned
EOLS Evolus, Inc.
19 Mar 2024
Avelar Rui See Remarks
Sold at will
$384.35K 27,603 at 13.92
6.9%
Not planned
EOLS Evolus, Inc.
22 Feb 2024
MOATAZEDI DAVID See Remarks
Sold on a plan
$100.80K 7,706 at 13.08
1.0%
Planned (10b5-1)
EOLS Evolus, Inc.
30 Jan 2024
Parschauer Karah Herdman Director
Sold on a plan
$156.73K 11,931 at 13.14
27.6%
Planned (10b5-1)
EOLS Evolus, Inc.
8 Dec 2023
MOATAZEDI DAVID See Remarks
Sold at will
$304.51K 31,300 at 9.73
4.9%
Not planned
EOLS Evolus, Inc.
6 Dec 2023
MOATAZEDI DAVID See Remarks
Sold at will
$517.89K 51,348 at 10.09
7.5%
Not planned
EOLS Evolus, Inc.
16 Oct 2023
Medytox Inc. Former 10% Owner
Sold at will
$12.68M 1,690,663 at 7.50
33.3%
Not planned
EOLS Evolus, Inc.
16 Aug 2023
MOATAZEDI DAVID See Remarks
Sold on a plan
$151.77K 14,778 at 10.27
2.1%
Planned (10b5-1)
EOLS Evolus, Inc.
15 Aug 2023
Malik Vikram Director
Bought
$1.30M 174,967 at 7.41
174%
First buy on file
EOLS Evolus, Inc.
14 Mar 2023
MOATAZEDI DAVID See Remarks
Sold, plan not stated
$543.80K 64,211 at 8.47
9.4%
EOLS Evolus, Inc.
14 Mar 2023
Avelar Rui See Remarks
Sold, plan not stated
$126.24K 14,906 at 8.47
4.2%
EOLS Evolus, Inc.
17 Feb 2023
Alphaeon 1 LLC 10% owner
Sold, plan not stated
$15.54M 1,850,000 at 8.40
30.5%
EOLS Evolus, Inc.
7 Feb 2023
Medytox Inc. 10% owner
Sold, plan not stated
$18.59M 2,187,511 at 8.50
30.1%
EOLS Evolus, Inc.
20 Jan 2023
Medytox Inc. 10% owner · indirect
Sold, plan not stated
$408.95K 37,043 at 11.04
0.5%
EOLS Evolus, Inc.
6 Oct 2022
Medytox Inc. 10% owner
Sold, plan not stated
$344.42K 38,304 at 8.99
0.5%
EOLS Evolus, Inc.
15 Sep 2022
Medytox Inc. 10% owner
Sold, plan not stated
$248.10K 24,000 at 10.34
0.3%
EOLS Evolus, Inc.
14 Sep 2022
Medytox Inc. 10% owner
Sold, plan not stated
$749.67K 73,000 at 10.27
1.0%
EOLS Evolus, Inc.
9 Sep 2022
Medytox Inc. 10% owner
Sold, plan not stated
$217.91K 20,700 at 10.53
0.3%
EOLS Evolus, Inc.
8 Sep 2022
Medytox Inc. 10% owner
Sold, plan not stated
$158.98K 15,300 at 10.39
0.2%
EOLS Evolus, Inc.
6 Sep 2022
BLANK SIMONE Director
Bought
$184.84K 20,000 at 9.24
57.3%
First buy on file
EOLS Evolus, Inc.
1 Aug 2022
Medytox Inc. 10% owner
Sold, plan not stated
$345.36K 26,000 at 13.28
0.3%
EOLS Evolus, Inc.
18 May 2022
SILVERNAIL LAUREN P See Remarks
Sold, plan not stated
$646.03K 52,015 at 12.42
26.9%
EOLS Evolus, Inc.
17 May 2022
SILVERNAIL LAUREN P See Remarks
Sold, plan not stated
$225.35K 16,189 at 13.92
7.7%
EOLS Evolus, Inc.
16 May 2022
MOATAZEDI DAVID See Remarks
Sold, plan not stated
$754.31K 55,321 at 13.64
10.1%
EOLS Evolus, Inc.
8 Mar 2022
MOATAZEDI DAVID See Remarks
Sold, plan not stated
$369.29K 37,972 at 9.73
6.4%
EOLS Evolus, Inc.
2 Sep 2021
Alphaeon 1 LLC 10% owner
Sold, plan not stated
$24.68M 2,597,475 at 9.50
30.0%
EOLS Evolus, Inc.
27 Aug 2021
Medytox Inc. 10% owner
Bought
$557.57K 51,000 at 10.93
0.7%
EOLS Evolus, Inc.
26 Aug 2021
Medytox Inc. 10% owner
Bought
$727.41K 66,000 at 11.02
0.9%
EOLS Evolus, Inc.
25 Aug 2021
Medytox Inc. 10% owner
Bought
$489.39K 44,000 at 11.12
0.6%
EOLS Evolus, Inc.
24 Aug 2021
Medytox Inc. 10% owner
Bought
$807.03K 72,219 at 11.17
1.0%
Largest buy in 3 yrs
EOLS Evolus, Inc.
23 Aug 2021
Medytox Inc. 10% owner
Bought
$769.78K 69,781 at 11.03
1.0%
Largest buy in 3 yrs
EOLS Evolus, Inc.
23 Aug 2021
Malik Vikram Director · indirect
Sold, plan not stated
$286.72K 26,077 at 11.00
2.2%
Showing 1–50 of 88. Page 1 of 2 Older →